Cargando…

A matched case-control study on the effectiveness of extracorporeal cytokine adsorption in critically ill patients

Extracorporeal cytokine adsorption aims to reduce cytokine levels in critically ill patients. However, little convincing data exist to support its widespread use. This retrospective study compared interleukin-6 (IL-6) levels in patients treated with or without cytokine adsorber (CytoSorb®). Intensiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jerman, Alexander, Gubenšek, Jakob, Berden, Jernej, Peršič, Vanja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439174/ https://www.ncbi.nlm.nih.gov/pubmed/37596304 http://dx.doi.org/10.1038/s41598-023-40719-z

Ejemplares similares

Extracorporeal Removal of Myoglobin in Patients with Rhabdomyolysis and Acute Kidney Injury: Comparison of High and Medium Cut-Off Membrane and an Adsorber Cartridge
por: Jerman, Alexander, et al.
Publicado: (2022)

Extracorporeal myoglobin removal in severe rhabdomyolysis with high cut-off membranes—intermittent dialysis achieves much greater clearances than continuous methods
por: Gubensek, Jakob, et al.
Publicado: (2021)

Effect of CytoSorb Coupled with Hemodialysis on Interleukin-6 and Hemodynamic Parameters in Patients with Systemic Inflammatory Response Syndrome: A Retrospective Cohort Study
por: Persic, Vanja, et al.
Publicado: (2022)

Regional citrate anticoagulation for intermittent hemodialysis in the intensive care: what is the optimal setup?
por: Gubensek, Jakob, et al.
Publicado: (2021)

Comparable Triglyceride Reduction With Plasma Exchange and Insulin in Acute Pancreatitis – A Randomized Trial
por: Gubensek, Jakob, et al.
Publicado: (2022)

Cytokine Adsorption in Critically Ill Patients Requiring ECMO Support
por: Lother, Achim, et al.
Publicado: (2019)

Extracorporeal Cytokine Removal in Critically Ill COVID-19 Patients: A Case Series
por: Virág, Marcell, et al.
Publicado: (2021)

Extracorporeal cytokine adsorption as an alternative to pharmacological inhibition of IL-6 in COVID-19
por: Supady, Alexander, et al.
Publicado: (2020)

First Experience With Extracorporeal Cytokine Adsorption Therapy After Lung Transplantation
por: Peyneau, Marine, et al.
Publicado: (2022)

Prevalence of Impaired Physical Mobility in Dialysis Patients: A Single-Centre Cross-Sectional Study
por: Bogataj, Špela, et al.
Publicado: (2023)

Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation
por: Rieder, Marina, et al.
Publicado: (2020)

Extracorporeal cytokine adsorption reduces systemic cytokine storm and improves graft function in lung transplantation
por: Ehrsam, Jonas Peter, et al.
Publicado: (2023)

The blind spot in high-dose tigecycline pharmacokinetics in critically ill patients: membrane adsorption during continuous extracorporeal treatment
por: Honore, Patrick M, et al.
Publicado: (2015)

Cost-effectiveness in extracorporeal life support in critically ill adults in the Netherlands
por: Oude Lansink-Hartgring, Annemieke, et al.
Publicado: (2018)

Nonischemic ST segment elevation in hypertrophic cardiomyopathy due to chest wall deformity from kyphoscoliosis
por: Blinc, Aleš, et al.
Publicado: (2010)

Meropenem Pharmacokinetics and Target Attainment in Critically Ill Patients Are Not Affected by Extracorporeal Membrane Oxygenation: A Matched Cohort Analysis
por: Gijsen, Matthias, et al.
Publicado: (2021)

Transportation of Critically Ill Patients on Extracorporeal Membrane Oxygenation
por: Broman, L. Mikael, et al.
Publicado: (2016)

Advances in Extracorporeal Support Technologies in Critically Ill Children
por: Yuerek, Mahsun, et al.
Publicado: (2023)

Critical Illness in Patients with Multiple Sclerosis: A Matched Case-Control Study
por: Karamyan, Anush, et al.
Publicado: (2016)

Application of extracorporeal therapies in critically ill COVID-19 patients
por: ZHOU, Zhifeng, et al.
Publicado: (2021)

Antifungal Dosing in Critically Ill Patients on Extracorporeal Membrane Oxygenation
por: Lyster, Haifa, et al.
Publicado: (2023)

Urinary and plasma cytokines in the critically ill
por: Adam, Z, et al.
Publicado: (2006)

The role of apheresis and insulin therapy in hypertriglyceridemic acute pancreatitis—a concise review
por: Gubensek, Jakob
Publicado: (2023)

The Role of Ultrasound Examination in the Assessment of Suitability of Calcified Arteries for Vascular Access Creation—Mini Review
por: Gubensek, Jakob
Publicado: (2023)

Clinical experience of using a novel extracorporeal cytokine adsorption column for treatment of septic shock with multiorgan failure
por: Sathe, P, et al.
Publicado: (2015)

Extracorporeal cytokine adsorption: Significant reduction of catecholamine requirement in patients with AKI and septic shock after cardiac surgery
por: Boss, Kristina, et al.
Publicado: (2021)

Voriconazole Pharmacokinetics in Critically Ill Patients and Extracorporeal Membrane Oxygenation Support: A Retrospective Comparative Case-Control Study
por: Ronda, Mar, et al.
Publicado: (2023)

Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation: protocol for a randomised, controlled, open-label intervention, multicentre trial
por: Rieder, Marina, et al.
Publicado: (2021)

Can the cytokine adsorber CytoSorb(®) help to mitigate cytokine storm and reduce mortality in critically ill patients? A propensity score matching analysis
por: Scharf, Christina, et al.
Publicado: (2021)

Kinetics of Plasma Cytokines During Two Different Modalities of Extracorporeal Blood Purification in the Critically Ill Covid 19 Patients: A Cohort Study
por: Ponce, Daniela, et al.
Publicado: (2022)

Impact of a VA–ECMO in Combination with an Extracorporeal Cytokine Hemadsorption System in Critically Ill Patients with Cardiogenic Shock–Design and Rationale of the ECMOsorb Trial
por: Haertel, Franz, et al.
Publicado: (2023)

Population Pharmacokinetics of Meropenem in Critically Ill Korean Patients and Effects of Extracorporeal Membrane Oxygenation
por: Lee, Dong-Hwan, et al.
Publicado: (2021)

Effect of extracorporeal hemoadsorption in critically ill patients with COVID-19: A narrative review
por: Chang, Kaixi, et al.
Publicado: (2023)

Lower serum cholesterol levels as a risk factor for critical illness polyneuropathy: a matched case–control study
por: Zulehner, Gudrun, et al.
Publicado: (2023)

Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial
por: Supady, Alexander, et al.
Publicado: (2021)

Current Applications for the Use of Extracorporeal Carbon Dioxide Removal in Critically Ill Patients
por: Camporota, Luigi, et al.
Publicado: (2016)

Population pharmacokinetics of remifentanil in critically ill patients receiving extracorporeal membrane oxygenation
por: Yang, Seungwon, et al.
Publicado: (2017)

Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies?
por: Honore, Patrick M., et al.
Publicado: (2018)

Nursing of Patients Critically Ill With Coronavirus Disease Treated With Extracorporeal Membrane Oxygenation
por: Tu, Zhongyu, et al.
Publicado: (2020)

Influence of transfusions, hemodialysis and extracorporeal life support on hyperferritinemia in critically ill patients
por: Knaak, Cornelia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0n9vo2ndfpplem6r4n3s5l8obm